Emmanuel Martin

Chief Operating Officer at INTEGRAGEN

Health Services

Health Technology

Consumer Services

Profile

Emmanuel Martin is currently the Chief Operating Officer at IntegraGen SA. Previously, he worked as a Principal at Applied Biosystems, Inc. Mr. Martin completed his undergraduate and graduate degrees at Université de Paris 5 René Descartes.

Emmanuel Martin active positions

Companies	Position	Start
INTEGRAGEN	Chief Operating Officer	-

All active positions of Emmanuel Martin

Former positions of Emmanuel Martin

Companies	Position	End
Applied Biosystems, Inc. Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million.	Corporate Officer/Principal	-

See the detail of Emmanuel Martin's experience

Training of Emmanuel Martin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Emmanuel Martin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INTEGRAGEN	Health Services

Private companies	2
Applied Biosystems, Inc. Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million.	Health Technology
Université de Paris 5 René Descartes	Consumer Services

Private companies

Health Technology

Université de Paris 5 René Descartes

Consumer Services

See company connections